Testing a new tracer on vulvar cancer tissue
Part of Cancer clinical trials.
This study is testing a new imaging tracer (a substance that helps see cancer on scans) on tissue samples from people with vulvar cancer. It aims to see if this tracer can help better identify cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with invasive vulvar cancer of the squamous cell type
- Stored tissue samples from the primary tumor or removed lymph nodes are available
- Samples are in good condition and not fully used up
- Clinical and pathology records are available
- No other active cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with early-stage vulvar cancer that can be surgically removed. It looks at the cancer's HPV and p53 status to decide how much tissue to remove, aiming to reduce side effects while keeping the cancer away.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This study tests whether a special dye injection can reliably find the first lymph node that might contain cancer in women whose vulvar cancer has come back for the first time. It aims to help doctors know if the cancer has spread without removing many lymph nodes.
This study looks at two tumor test results—HPV and p53—to help doctors decide how much tissue to remove during surgery for vulvar squamous cell carcinoma. It’s meant to reduce the risk of the cancer coming back while avoiding unnecessary removal when margins are only close.
Hear when a new Vulvar Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.